Cargando…

Symptomatic hyponatremia during glomerular filtration rate testing

Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associated with significant morbidity and mortality, and is therefore important to recognize. Prior reports have linked duloxetine with hyponatremia, but it is uncommon. In this case report, we describe a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Balaram, Manjunath, Ford, Virginia, Townsend, Raymond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421406/
https://www.ncbi.nlm.nih.gov/pubmed/25949461
http://dx.doi.org/10.1093/ndtplus/sfq166
_version_ 1782369861924552704
author Balaram, Manjunath
Ford, Virginia
Townsend, Raymond
author_facet Balaram, Manjunath
Ford, Virginia
Townsend, Raymond
author_sort Balaram, Manjunath
collection PubMed
description Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associated with significant morbidity and mortality, and is therefore important to recognize. Prior reports have linked duloxetine with hyponatremia, but it is uncommon. In this case report, we describe a research subject taking duloxetine who developed severe symptomatic hyponatremia during glomerular filtration rate testing despite having undergone such testing uneventfully in the past.
format Online
Article
Text
id pubmed-4421406
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-44214062015-05-06 Symptomatic hyponatremia during glomerular filtration rate testing Balaram, Manjunath Ford, Virginia Townsend, Raymond NDT Plus Case Report Hyponatremia affects nearly one in five of all hospitalized patients. Severe hyponatremia is associated with significant morbidity and mortality, and is therefore important to recognize. Prior reports have linked duloxetine with hyponatremia, but it is uncommon. In this case report, we describe a research subject taking duloxetine who developed severe symptomatic hyponatremia during glomerular filtration rate testing despite having undergone such testing uneventfully in the past. Oxford University Press 2010-12 2010-09-22 /pmc/articles/PMC4421406/ /pubmed/25949461 http://dx.doi.org/10.1093/ndtplus/sfq166 Text en © The Author 2010. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Case Report
Balaram, Manjunath
Ford, Virginia
Townsend, Raymond
Symptomatic hyponatremia during glomerular filtration rate testing
title Symptomatic hyponatremia during glomerular filtration rate testing
title_full Symptomatic hyponatremia during glomerular filtration rate testing
title_fullStr Symptomatic hyponatremia during glomerular filtration rate testing
title_full_unstemmed Symptomatic hyponatremia during glomerular filtration rate testing
title_short Symptomatic hyponatremia during glomerular filtration rate testing
title_sort symptomatic hyponatremia during glomerular filtration rate testing
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4421406/
https://www.ncbi.nlm.nih.gov/pubmed/25949461
http://dx.doi.org/10.1093/ndtplus/sfq166
work_keys_str_mv AT balarammanjunath symptomatichyponatremiaduringglomerularfiltrationratetesting
AT fordvirginia symptomatichyponatremiaduringglomerularfiltrationratetesting
AT townsendraymond symptomatichyponatremiaduringglomerularfiltrationratetesting